Cachectin (Tumor Necrosis Factor) 1. lts structure, biosynthesis and biological effects

O. Şadi Yenen

doi:10.58600/eurjther.19900101-519

Authors

O. Şadi Yenen GATA, Haydarpaşa Eğitim Hast. İnfeksiyon Hastalıkları ABD

DOI:

https://doi.org/10.58600/eurjther.19900101-519

Abstract

In recent years, particular interest has been focused on tr9 newly charateri zed multipotent monokine: Cachectin (Tumor necrosis factor ). This paper sur veys its historical exploration, structure, biosynthesis and biological effects on cells and tissues.

Metrics

Metrics Loading ...

References

Aderka D.Holtmann H, Toker L, Hahr T, Wallach O: Tumor necrosis factor induction by Sendai virus. J lmmunol 136:2938, 1986

Agah R, Malloy B, Sherrod A, Bean P, Girgis E, Manzumder A: Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor. J Biol Response Modifiers 7:140, 1988

Aggarwal BB, eessaalu TE, Hass PE: Characterization fo receptors for human tumor necrosis factor and their regulation by gamma- interferon. Natura 318:665,1985

Aggarwal BB, Henzel WJ, Harkins RN: Primary structure of human lymephotoxin derived from 1788 lymphblastoid celi line. J Biol Chem 260:2334, 1985

Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS; Nedwin GE, Goeddel OV, Harkins RN: Human tumor necrosisi factor: Poduction, purification, and characterization. J Biol Chem 260:2345, 1985

Aggarwal BB, Moffat B, Harkins RN: Human lymphotoxin. J Biol Chem 259:686, 1984

Aggarwal BB, Trafuina PR, Eessaalu TE: Modulation of receptors and cytotoxic response of tumor necrosis factor - by various lectins. J Biol Chem 261: 13652, 1986

Ailen RA, Traynor AE, omann GM, Jesaitis AJ: The chemotactic peptide receptor: A model lor future understanding of chemotactic disorders. Hemotol/Oncol Clin North Amer 2:33, 1988

Arenzana-Seisdedos F, Mogensen SC, Vuillier F, Fiers W, Virelizire J-L: Autocrine secretion of tumor necrosis factor under the influence of interfero- amplifier HLA-DR gene induction in human monocytes. Proc Natl Acad Sci USA 85: 6087, 1988

Atkinson YH, Marasco WA, Lopez AF, Vadas MA: Recombinant human tumor necrosis factor : Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin İnvest 81 :759, 1988

Bachwich PR; Chensue SW, Larrick JW, Kunkel SL: Tumor necrosis factor stimulates IL-I and PGE2 production in resting macrophages Biochem Biophys Res Commun 136: 94,1986

Baglioni C, McCandles S, Tavernier J, Fiers W: Binding of human tumor necrosis factor to high affinity receptors on Hela and lymphoblastoid cells sensitive to growth inhibition, j Biol Chem 260:13395, 1985

Balkwill FR, Lee A,Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W: Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cacer Res 46:3990, 1986

Balwill FR, Ward BG, Fiers W: Effects of tumournecrosis factor on human tumor xenografts in nude mice. Tumor Necrosis Factor on Related Related Cytotoxins, (Ed: Bock G, Marsh J)'de. Ciba Foundation Symposium, No:131, Jeohn Wiley and Sons, Chichester, 1987, s 154

Bertolini DR, Nedwin GE, Bringman TS; Smith DD, Mundy GA: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516. 1986

Beutler B, Cerami A: Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584, 1986

Beutler B, Greenwald D, Hulmes JD, Chang M, Pan Y-CE, Mathison J, Ulevitch R, Cerami A: ldentity of tumour necrosis factor and the rnacrophage-secreted factor cachectin. Nature 316:552, 1985

Beutler B, Kochin n, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 231:977, 1986

Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A: Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin- induced RAW 264. 7 cells. J Exp Med 161: 984, 1985

Beutler B,Milsark IW, Cerami A: Cachectin/tumor nerosis factor: production, distribution, and metabolic lale in vivo. J lmmunol 135: 3972, 1985

Bevilagua MP, Pober JS, Majeau GR, Fiers W, Cotran RS; Gimbrone MA jr: Recombinant tumor necrosis factor induces porcoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Porc Natl Acad Sci USA 83:4533, 1986

Bingel M, Lonnemann G,Shaldon S, Koch KM, Dinarello CA: Human interleukin -1 production during hemodialysis. Nephron 43:161, 1986

Boglioni C, Ruggiere V, Latham K, Öohnson SE: Cytocidal activity of tumour necrosis factor: Protection by protease inthibitors. Tumour Necrosis Factor and Related Cytotoxins, (Ed: Bock G, Marsh J)'de. Ciba Foundation Symposium No:131, Chichester, John Wiley and Sons, 1987, s 52

Broudy VC, Harlan jM, Adamson JW: Disparate effects of tumor necrosis factor-alpha/cachoctin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrofhil adhesion molecule expression by cultured human endothelial celles. J lmm_unol 138: 4298, 1987

Broxmeyer HE, Williams DU, Lu L: The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-.J lmmuunol 136: 4487, 1986

Caput D, Beutler Hartog K, Brown-Shimer S, Cerami A: :dentification of a comman nucleotid sefuence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670, 1986

Carswell EC, Old LJ,, KasselRL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666, 1975

Cerami A, Ykeda Y, Le Trang N, Hotez PJ, Beutler B: Weight loss associated with an endotoxininduced mediator from peritoneal macrophages: The role of cachectin (Tumor necrosis factor). lmmun Lett 11:173, 1985

Choaib S, Bertoglio J, Blay J-Y, Marchiol-Fournigault C, Fradelizi D: Generaltion of lympohokine activated killer celles: Synergy between tumor necrosis factor and interleukin-2. Proc Natl Acad Scii USA 85:6875, 1988

Chiristmas SE, Meager A, Moore M: Production of interferon and tumor necrosis factor by cloned human natural cytotoxic lymphocytes ant T cells. Clin Exp lmmunol 69: 441, 1987

Clark IA: Suggested importance of monokines inpathopysiology of endotoxic shock and malaria. Kiln Wochenschr 60:756, 1982

Coley Wb: The treatment of malignant tumors by refaated inoculations of erysipelas; with a report of ten original cases. Am j Med Sci 105: 487, 1983

Collart MA, Belin D, Vassali JD, Vassali JD, de kossoda P: Gamma- interferon enhances macrophages transcription of the tumor necrosis factor/ cachectin, interleukin 1, and urokinase genes, which are controlled by short lived repressors, j Exp Med 164:2113, 1986

Coılins T, Lapierre LA, Fiers W, Strominger jl, Pober jS: Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial celles and dermal fibroblasts in vitro. Proc Nalt Acad Sci USA 83:446, 1986

Cordingley FT, Bianchi A, Hoffbrand AV, Reittie JE, Heslop HE, Vyakarnam A, turner M, Meager A, Brenner MK: Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet i:969, 1988

Creasey AA; Reynolds MT, Laird W: Cures partial regression fo murine and human tumors buyrecombinant human tumor necrosis factor. Cancer Res 46:5687, 1986

Degliantoni G, Murphy m, Kobayshi M,Francis MK, Perussia b, Trinchieri G: Natural killer (NK0 cell-derived hematopoitic colony-inhibiting actiivity and NK cytotoxic factor: Relationship with tumor necrosis factor and synergism with immune interferon. j Exp Med 162: 1512, 1985

Djeu jY, Blanchard DK, Halkias D, Friedman H: Growth intibition of Candida albicans by human polymorphonuclear neutrophilk: Activation by interferon gamma and tumor necrosis factor. J lmmuunol 137:2980, 1986

Enders S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, Van der Meer JWM, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer AJ, wolff SM, Dinarello CA: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by monouclear celles. N Engl J Med 320:265, 1989

Feinman R, Henriksen-Destefano D, Tsujimoto M, Vilcek J: Tumor necrosis factor is an important mediator of tumor celi killing by human monocytes. j lmmunol 138:635, 1987

Flick DA, Gifford GE, Tumor necrosis factor. Biological Response Modifiers New approaches to Disease lntervention, (Ed: Torrence PF)'de. New York, Acedemic Press, 1985, s 171

Fransen L, Muller R, Marmenout A, Tavernier J, Van der Heyden J, Kawashima E, Chollet A, Tizard R, Van Heuverswyn H,Van Vliet A, Ruysschaort M-R, Fires W: Molecular cloning of mouse tumor necrosis factor cDNA ant its eukaryotic eukaryotic expression. Nucl Acids Res 13:4417,1985

Fransen L, Van der Heyden J, Ruysschaert M-R, Fiers W: Recombinant tumor necrosis factor: lts effect and synergism with interferon-gama on a variety of normal and transformed human celi lines. Eur J Cancer Clin Oncol 22: 419, 1989

Gamble JR, Harlan JM, Klebanoff Sj, Vadas MA: Slimulation of the adherence of neuntrophils to umblical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82:8667, 1985

Granger GA, Williams TW: Lymphocyte cytotoxicity in vitro. Ar ·ation and release of a cytotoxic factor. Natura 218:1253, 1968

Gray PW, Aggarwal 88, 8enton CV, 8ringman TS, Henzeı WJ, Jarrett JA, Leung DW, Moffat 8, Ng P, Svedersky Lp, Palladino MA, Nedwin GE: Cloning and expression of cDNA for human lymhotoxin, a lymphokine with tumor necrosis activity. Natura 322:721, 1984

Haranaka K, Satomi N, Sakurai A: Anlitumor aclivity of murine tumor necrosis factor (TNF) against transplanted murine tumors, and heterotransplanted hum an tumors in nude mice. lnt J Cancer 34:263, 1984

Haranaka K, Satomi N, Sakurai A, Haranaka R : Antitumors effects of tumour necrosis factor : Cytotofic or necrotizing activity and its mechanisl. Tumour Necrosis Factor and Related Cystotoxins, (Ed: 8ock G, Marsh J)'de, Ciba Foundation Symposium No:131, Chichester, John Wiley and Sons, 1987, s 140

Haranaka K, Satomi N, Sakurai A, Kunii O: Role of Lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis fector and liypopolysaccharide. Tohoku J Exp Med 144:385 , 1984

Hartwell JL, Shear MJ, Adams JR Jr: Chemical treatment of tumors VII. Natura of the hemorrhageproducing fraction from Serralia marcescens (8acillus prodigiosus) cultrue fitrate. J Natl Cancer insi 4:107, 1943

Hass PE, Hotchkiss A, Mohler M, Aggarwal 88: Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.J 8iol Chem 260:12214, 1985

Helmman L (Ed): The selected letters of Anten Chekhov. London: Pan 8ooks Ltd, 1984, s 134 (Gresser 1: A. Chekhov, MD, and Coley's Toxins. N Engl j Med 317:457, 1987)'den alınmıştır.

Hotez Pj, Le Trang N, Fairlamb AH, Cerami A: Lipoprotein lipase suppression in 3T3-LI cells by a haemato-protozoan-induced mediator from peritoneal exudate cells. Parasite lmmunol 6:203, 1984

Jadus MR, Schmunk G, Djeu JY, Parkman R: Morpholog and lytic mechanisms of interleukin-3-dependent natural cytotoxic cells: Tumor necrosis factor as a possible mediator. J lmmunol 137:2774, 1986

Jelinek OF, Lipsmy PE: Enhancement of human 8 celi proliferation and differentiation by tumor necrosis factor- and interleukin-1. J lmmunol 139:2970 , 1987

Jones EY, Stuart Dl, Walker NPC: Structure of tumur necrosis factor. Natura 338:225, 1989

Kahlar H, Shear MJ, Hartwell JI: Chemical treatment of tumors VIII. Ultracentrifugal and electrophorelic analysis of the hemorrhage-producing fraclion from Serralia marcescens (8acillus prodigiosus) culture filtrate. J Nath Cancer insi 4:123, 1943

Kawakami M, Cerami A: Studies of endotoxin-induced recrease in lipoprotein lipase activity. J Exp Med 154: 631, 1981

Kawakami M, Pekala PH, Lane MD, Cerami A: Lipoprotein lipase suppression in 3T3-L 1 cells by an edotoxin-induced mediator from exudate vells. Proc Natl Acad Sci USA 79:912. 1982

Kehrl JH, Miller A, Fauci AS: Effect of TNF on mitogen activated human 8 cells. J Exp Med 166:786, 1987

Kildahl-Andersen O, Nissen-Meyer J: Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptide. Celi lmmunol 93:375, 1985

Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM: Stimulation of neutrophils by tumor necrosis factor. J İmmunol 136: 4220, 1986

Kobayashi M, Plunkett JM, Masunaka IK, Yamamato RS, Granger GA: The human L T system XII. Purification and functional studies of L T ant "TNF-like" L T forms from a continuous human T celi line. J lmmunol 137:1885, 1986

Kornbluth RS, Edgington TS: Turne• necrosis factor production by human monocytes is a regulated event: lnduction of TNF-alpha-mediated celiular cytotoxicity by endotoxin. J lmmunol 137 : 2585, 1986

Kull FC, Guatrecasas P: Possible reguirement of internalization in the mechanisrns of in vitro cytotoxicity in tumor necrosis serum. Cancer Res 41:4885, 1981

Kuli FC, Jacobs S, Cuatrecasas P: Cellular receptor lor 1251-Labeled tumor necrosis factor: Specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci USA 82:5756,1985

Lam KS, Scuderi P, Salmon SE: Analysis of the molecular organization of recombinant human tumor necrosis factor (rTNF} in solution using ethylene glycolbis (sucinimidylsuccinate) as the cross-linking reagent. J Biol Response Mod , :267, 1988

Le J, Vilcek J: Tumor necrosis factor and interleukin-1: Cytokines with multiple overlappir,g biological activities. Lab lnvest 56:234, 1987

Lee DM, Zentalia A, Vine W Pekala PH, Cerami A: Effect of endotoxin induced monokines on glucose metobolism in the muscle celi line L-6. Proc Natl Acad Sci USA 84:2590, 1987

Lee SH; Aggawal BB, Rinderknect E, assisi F, Chiu H: The synergistic anti-proliferative effect of-interferon and human ıymphotoxin. J lmmunol 133:1083,1984

Libby P, ordoves JM; Auger KR, Robbines AH,Birinyi LK, Dinarelio CA: Endotoxin and tumor necrosis factor induce interleukin-1 gene expressi in adult human vascular endothelial celis. Am J Pathol 124:179,1986

Lonnemann G,Van der Meer JWM, Cannon JG, Dinarello CA, Koch KM, Grenolleras C, Descholdt G, Shaldon S: lnduction of tumor necrosis factor during extracorporeal blood purification. N Engl J Med 317:963, 1987

Mannel DN, Moore RN, Mergenhagen SE: Macrophages as a source of tumoricedal activity (tumor necroziting factor). lnfect lmmun 30:523, 1980

Mathews N: Tumor necrosis factor from the rabbit 11.Production by monocytes. Br J Cancer 38:310,1978

Mathews N: Tumor necrosis factor from the rabbit V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits Br J Cancer 44:418, 1981

Mathews N: Production of an anti-tumor cytotoxin by human nonocytes. lmmunology 44: 135, 1981

Movat HZ: Tumor necrosis factor and lnterleukin-1: Role in acute inflammation and microvascular injury. J Lab Clin Med 110:668, 1987

Munker R, Gasson J, Ogawa M,Koeffler HP: Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Natura 323:79, 1986

Nawroth PP,Bank 1, Handley D, Cassimeris J, Chess L, Stern D: Tumor nerosis factor/cachectin interacts with endothelial celi receptor to induce release of interleukin-1. J Exp Med 163:1363, 1986

Nawroth PP, Stern DM: Modulation of endothelial celi hemostatic properties endothelial celi hemostatic properties by tumor necrosis factor. J Exp Med 163:740, 1986

Nedwin GE, Svedersky LP,Bringman TS, Palladino MA, Goeddel DV: Effect of Jnterleukin 2, interferon- and mitogens on the production fo tumor necrosis factors and J lmmunol 135:2492, 1985

Niitsu Y, Watanabe N, Sone İH, Neda H, Yamauchi N, Maeda M, Urushizaki 1: Analysis of the TNF receptor on KYM celis by binding assay and affinity cross-linking. J Biol Response Mod 7:276, 1988

Niiitsu Y, Watanabe N, Sone H, Neda H,Yamauchi İn, Urushizaki 1: Mechanism of the cytotoxic effect of tumor necrosis factor. jpn j Cancer Res 76:1193, 1985

Old LJ: Tumor necrosis Pactor (TNF). Science 230:630, 1985

Old LJ: Polypeptide mediator network. Nature 326:330, 1987

Ortaldo JR, Mason LH, Mathieson BJ, Liang SM, Flick DA, Herberman RB: Mediation fo mouse natura! cytotoxic activity by tumor necrosis factor. Nature 321 :700, 1986

Ostensen ME, Thiele DL, Lipski PE: Tumor necrosis factor-alpha enhances cytolitic activity of human natura! killer cells. J lmmunol 138: 4185, 1987

Palladino MA, Shalaby MR, Kramer SM, Ferraiolo BL,Baughman RA, Deleo AB, Crase D, Marafino B,Aggarwaal BB, Figari İIS, Liggilt D, Palton JS: Characterization of the antitumor activies of human necrosis factor and the comparison with the other cytokines: lnduction of tumor-specific immunity. J lmmunol 138: 4023, 1987

Palton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C: lnterferons and tumor necrosis factors have similar catabolic effects on 3T3 LI cells. Proc Natl Acad Sci USA 83:8313, 1986

Peetre C, Gullberg U, Nilsson E, Olsson, 1: Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro.Relationship to celi surface receptor. J Clin lnvest 78:1694, 1986

Pekala PH, Kawakami NM, Angus CW, Lane MD, Cerami A: Selective inhibition of synthesis of enzymes for "de novo" falty acid biosynethesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA 80:2743, 1983

Pekala PH, Price SR, Horn CA, Hom BE, Moss J, Cerami A: Model for cachexia in chronic disease:Secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L 1 adipocytes. Trans Assoc Am Physicians 97:251,1984

Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV:s Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Nalt Acad Sci USA 82:6060, 1985

Pennica D,Nedwin GE, Hayflick jS, Seeburg PH, Derynck R, Palladino MA, Kohr wj, Aggarwal BB, Goeddel DV: Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312: 724, 1984

Petersen CM, Meller BK: lmmunological reactivity and bioactivity of tumor necrosis factor. Lancet i:934, 1988

Pohlman TH; Stanness KA, Bealty PG, Ohs HD, Harlan JM: An endothelial celi surface facter(s) induced in vitre by lipopolysaccharide, interleukin 1 and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18- dependent mechanism. J lmmunol 136:4548, 1986

Ralston SH: The pathogenesis of humoral hypercalcemia of maligmancy. lancet ii:144�. 1987

Ramila P,Epstein LB: Tumor necrosis factor as an immunomodulator and mediator of monocyte cytotoxicity induced by itself, -interferon and interleukin-ı. Nature 323:86, 1986

Rouzer CA, Cerami A: Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of effective triglyceride removal. Mol Biochem Parasitol 3:31, 1990

Rubin BY,Anderson SL, Sullivan SA, Wiliamson BD,Carswell EA, Old LJ: High affinity binding of 125 I-Labelled human tumor necrosis factor (LuKII0 to specific celi surface receptors. J Exp Med 162:1099, 1985

Saklatvala J: Tumorur necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547,1986

Sariban e,lmamura K, Luebbers R, Kufe D: Transcriptional and post transcriptional regulation of tumor necrosis factor gene expression in human necrosis factor gene experssion in human monocytes. J elin lnvest 81: 1506, 1988

Sassa S, Kawakami M, Cerami A: İnhibition of the growth and differentiation of erythroid precursor cells by an endotoxin-induced mediator from peritoneal macrophages. Proc Natl Acad Sci USA 79: 912, 1982

Sato N, Goto T, Haranaka K, Satomi N, Nariuchi N, Nariuchi H, Mano-Hirono Y, Sawasaki Y: Action of tumor necrosis factor on cultured vascular endothelial cells: Morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer lnst 76:1113, 1986

Satch M, lnagawa H, Shimada Y, Soma G, oshima H, Mizuno D: Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. J Biol Response Mod 6:512,1987

Scheurgich P, Maxeiner B, Ucer U, Pfizenmaier K: lnterferon gamma production by activated hyuman T lymphoctes is stimulated by tumor necrosis factor alpha. J lnterferon Res (Suppl 1) 6:112 (abs 111-43), 1986

Schellef RR,Bevilaque MP,Sawdey M, Gimbrone MA Jr, Loskutoff Dj: lnterleukin ı(IL-ı) and tumor necrosis factor (TNF) activation of vascular endothelium: Effects on plasminogen activator inhibitor (PAl-I) and tissue-type plasminogen activator (t PA). lnt Soc İThromb Haemostasis 58: 17(abs 65a), 1987

Shalaby MR, Aggarwal BB, Rinderknecht e, Svedersky LP, Finkle BS, Palladino MA: Activation of human polymorptıonuclear neutrophil functions by interferon and tumor necrosis factors. J lmmunol 135:2069, 1985

Shalaby MR, Palladino MR, Hirabayashi SE, Eessalu TE, Lewis GD, Shepard HM, Aggarwal BB: Receptor binding and activation of polymorphonuclear neutrophils by tumor nAcrosis factor- J Leukocyte Biol 41:196, 1987

SHear MJ: Chemical treatment of tumors IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide. J Natl Cancer lnst 4:461, 1944

Shear MJ, Turner FC: Chemical treatment of tumors V. lsolation of the hemorrhage-producing fraction from serratia marcescens (Bacillus prodigiosus) culture filtrate. J Natl Cancer lnst 4:81, 1943

Silberstein DS, David JR: Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 83:1055, 1986

Smith RA, Baglioni C: The active from of tumor necrosis factor is a trimer. j Biol Chem 262:6951, 1987

Sohumara Y, Nakata K, Yoshida H, Kashimoto G, Matsui Y, Furuchi H: Antitumor effect on murine and human tumors transplanted in mice. lnt J lmmunopharmacol 8:347, 1986

Spier T, Blanck G, Bresnahan M, Sands J, Strominger JL: A new cluster of genes within the major histocompatibility complex. Science 243:214, 1989

Spies T, Morton CC, Nedaspasov SA, Fiers W, Pious D, Strominger JL: Genes for the tumor necrosis factors and are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83:8699, 1986

Stolpen AH, Guinan EC, Fiers W, Pober JS: Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 123:1986

Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor : Effects on proliferation of normal and transformed cells in vitro. Science 230:943,1985

Takeda K, lwamoto S, Sugimoto H, Takuma T, Kawatani N, Nada M, Masaki A, Morise H, Arimura H, Konno K: ldetify of differentiation inducing factor and tumor necrosis factor. Natura 323:338, 1986

Torti FM, Dieckmann B,Beutler B, Cerami A, Ringold GM: A macrophage factor inhibits adipocyte gene expression: An in vitro model of cachexia. Science 229: 867, 1985

Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT: Cachectin tumor necrosis factor mediates changes in skletal muscle plasma membrane potential. J Exp Med 164:1368, 1986

Trinchieri G, Kobayashi M, Rosen M,Loudon R,Murphy M, Perussia 8: Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164:1206, 1986

Tsujimoto M, Yip K, Vilcek J: Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci USA 82:7626, 1985

Tsujimoto M, Yip K, Vilcek J: lnterferon- enhances expression of cellular receptors tor human necorosis factor. J lmmunol 136:2441, 1986

Tsujimoto M, Yokota S, Vilcek J, Veissman G: Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biopııys Res Commun 137:1094, 1986

Van Hinsberg VWM, Kooistra T, ,Fiers W, Emeis JJ: Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in vivo. J lnt Soc Thromb Haemostasis 58:15 (abs 59a), 1987

Wang AM, Creasey AA, Laduer MB, Lin LS, Strickler J, Van Arsdell JN, Yamamato R, Mark DF: Molecular cloning of the complementary DNA from human tumor necrosis factor. Science 228:149, 1985

Watanabe N, Niitsu Y: Antitumor effect and the mechanism of action of human recombinat TNF. Jpn J Cancer Chemother 13:1322, 1986

Williamson BD, Carswell EA, Rubin BY, Prendergast JS, Old LJ: Human tumor necrosis factor produced by human 8-cell lines: Synergiistic cytotoxic interaction with human interferon. Proc Natl Acad Sci USA 80; 5397, 1983

Wıngfield P, Pain RH, Craig S: Tumor necrosis factor is a compact trimer. FEBS Lett 211 ;179, 1987

Wong GHW, Goeddel DV: lnduction of manganous superoxide dismutase by tumor necrosis fac . tor: Possible protective mechanism. Science 242:941, 1988

Zacharchuk CM. Drysdale B-E, Mayer MM, Shin HS: Macrophage-mediated cytotoxicity: Role of a solubl macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. Proc Natl Acad Sci USA 80:6341, 1983

Zucali JR, Elfenbin GJ, Barth KC, Dinarello CA: Effects of human IL-1 and human TNF on human T lymphocyte colony formation. J Clin lnvest 80: 772, 1987